Stock Events

Stock Events

VitaSpring Biomedical 

$0.031800
2
+$0.02+186.49%Thursday 17:15

Statistics

Day High
0.5
Day Low
0.5
52W High
1
52W Low
0.0111
Volume
63
Avg. Volume
1
Mkt Cap
6.58M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Dec 21Expected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q3 2022
-0
-0
0
0
Expected EPS
N/A
Actual EPS
-0.0007

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-415,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. develops and produces therapeutics similar to VitaSpring Biomedical, focusing on innovative biotechnology treatments in areas overlapping with VSBC's interests.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. operates in the biopharmaceutical field, directly competing with VitaSpring Biomedical in the development of treatments for infectious diseases, a key area for VSBC.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. is known for its work in biopharmaceuticals, particularly in areas like immunology and oncology, which are also focus areas for VitaSpring Biomedical.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated specializes in creating drugs for complex diseases, competing with VitaSpring Biomedical in drug development and innovation.
Biogen
BIIB
Mkt Cap37.49B
Biogen Inc. focuses on neurological and neurodegenerative diseases, competing with VitaSpring Biomedical in the biotech sector, particularly in research and development.
Alnylam Pharmaceuticals
ALNY
Mkt Cap22.1B
Alnylam Pharmaceuticals, Inc. works on RNAi (RNA interference) therapeutics, a cutting-edge technology that could potentially overlap with VitaSpring Biomedical's biotechnological approaches.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation specializes in oncology products, directly competing with VitaSpring Biomedical in the cancer treatment market.
Exelixis
EXEL
Mkt Cap16.93B
Exelixis, Inc. is involved in the discovery, development, and commercialization of new medicines for cancer, competing in the oncology sector with VitaSpring Biomedical.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for rare diseases, a field that overlaps with some of VitaSpring Biomedical's therapeutic areas.

About

VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Show More
CEO
Ssu-Chuan Lai
Employees
1
Country
United States
ISIN
US92851B1026

Listings

OTC Link
US
VSBC

0 Comments

Share your thoughts

FAQs

What is VitaSpring Biomedical stock price today?▼
The current price of VSBC is $0.03 USD — it has increased by +186.49% in the past 24 hours. Watch VitaSpring Biomedical stock price performance more closely on the chart.
What is VitaSpring Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange VitaSpring Biomedical stocks are traded under the ticker VSBC.
Is VitaSpring Biomedical stock price growing?▼
VSBC stock has risen by +0% compared to the previous week, the month change is a +186.49% rise, over the last year VitaSpring Biomedical has showed a -96.82% decrease.
What is VitaSpring Biomedical market cap?▼
Today VitaSpring Biomedical has the market capitalization of 6.58M
What were VitaSpring Biomedical earnings last quarter?▼
VSBC earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is VitaSpring Biomedical revenue for the last year?▼
VitaSpring Biomedical revenue for the last year amounts to 0 USD.
What is VitaSpring Biomedical net income for the last year?▼
VSBC net income for the last year is -415,000 USD.
How many employees does VitaSpring Biomedical have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is VitaSpring Biomedical located?▼
VitaSpring Biomedical operates in the Health & Wellness sector.
When did VitaSpring Biomedical complete a stock split?▼
The last stock split for VitaSpring Biomedical was on June 29, 2020 with a ratio of 5:1.
Where is VitaSpring Biomedical headquartered?▼
VitaSpring Biomedical is headquartered in Riverside, United States.